Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.
Miller RG, Zhang R, Block G, Katz J, Barohn R, Kasarskis E, Forshew D, Gopalakrishnan V, McGrath MS. Miller RG, et al. Among authors: gopalakrishnan v. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):601-9. doi: 10.3109/21678421.2014.951940. Epub 2014 Sep 5. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 25192333 Free PMC article. Clinical Trial.
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A; Phase 2 Trial NP001 Investigators. Miller RG, et al. Among authors: gopalakrishnan v. Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 25884010 Free PMC article.
Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
Kadaikunnan S, Vijayaragavan P, Rathi MA, Balamuralikrishnan B, Alharbi NS, Gopalakrishnan VK, Purushothaman S, Sivanesan R. Kadaikunnan S, et al. Among authors: gopalakrishnan vk. J Infect Public Health. 2024 Mar;17(3):450-456. doi: 10.1016/j.jiph.2024.01.001. Epub 2024 Jan 6. J Infect Public Health. 2024. PMID: 38262082 Free article.
Beyond Binary: Gender Reassignment in a Case of 11β-Hydroxylase Deficiency.
Hithayathulla MA, Putta Nagarajan HD, Gopalakrishnan V, Puliyadi Rishi K, Chandrasekaran G. Hithayathulla MA, et al. Among authors: gopalakrishnan v. Cureus. 2023 Nov 11;15(11):e48644. doi: 10.7759/cureus.48644. eCollection 2023 Nov. Cureus. 2023. PMID: 38090464 Free PMC article.
Scar Endometriosis vs Hemangioma: A Diagnostic Conundrum.
Putta Nagarajan HD, Selvanathan K, Gopalakrishnan V, Ramamoorthy RV, Gopalakrishnan J. Putta Nagarajan HD, et al. Among authors: gopalakrishnan v. Cureus. 2023 Oct 25;15(10):e47674. doi: 10.7759/cureus.47674. eCollection 2023 Oct. Cureus. 2023. PMID: 38021669 Free PMC article.
Evaluation of potential role of R-loop and G-quadruplex DNA in the fragility of c-MYC during chromosomal translocation associated with Burkitt's lymphoma.
Kumari N, Das K, Sharma S, Dahal S, Desai SS, Roy U, Sharma A, Manjunath M, Gopalakrishnan V, Retheesh ST, Javadekar SM, Choudhary B, Raghavan SC. Kumari N, et al. Among authors: gopalakrishnan v. J Biol Chem. 2023 Dec;299(12):105431. doi: 10.1016/j.jbc.2023.105431. Epub 2023 Nov 4. J Biol Chem. 2023. PMID: 37926284 Free PMC article.
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial).
Kijak GH, Ahani B, Arbetter D, Chuecos F, Gopalakrishnan V, Beloor J, Brady T, Nguyen A, Roe TL, Schuko N, Zhang T, Hobbs FDR, Padilla F, Kelly EJ, Montgomery H, Streicher K. Kijak GH, et al. Among authors: gopalakrishnan v. Infect Dis Ther. 2023 Dec;12(12):2691-2707. doi: 10.1007/s40121-023-00882-2. Epub 2023 Nov 2. Infect Dis Ther. 2023. PMID: 37914983 Free PMC article.
377 results